XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Financial Instruments
3 Months Ended
Mar. 31, 2017
Financial Instruments  
Financial Instruments

4. Financial Instruments

The Company elected to invest a portion of its cash assets in conservative, income earning, liquid investments effective September 2015. Cash equivalents and investments, all of which are classified as available-for-sale securities, consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2017

 

December 31, 2016

 

 

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
(Loss)

    

Estimated Fair
Value

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
(Loss)

    

Estimated Fair
Value

 

 

 

(in thousands)

 

Money market deposits

 

$

520

 

$

 —

 

$

 —

 

$

520

 

$

10,777

 

$

 —

 

$

 —

 

$

10,777

 

U.S. Treasury securities

 

 

40,751

 

 

 —

 

 

(346)

 

 

40,405

 

 

57,846

 

 

 —

 

 

(404)

 

 

57,442

 

U.S. agency securities

 

 

50,160

 

 

 —

 

 

(152)

 

 

50,008

 

 

56,261

 

 

 —

 

 

(147)

 

 

56,114

 

Municipal securities

 

 

16,306

 

 

 5

 

 

(32)

 

 

16,279

 

 

17,478

 

 

 —

 

 

(174)

 

 

17,304

 

Total

 

$

107,737

 

$

 5

 

$

(530)

 

$

107,212

 

$

142,362

 

$

 —

 

$

(725)

 

$

141,637

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

$

520

 

 

 

 

 

 

 

 

 

 

$

10,777

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

106,692

 

 

 

 

 

 

 

 

 

 

 

130,860

 

Total

 

 

 

 

 

 

 

 

 

 

$

107,212

 

 

 

 

 

 

 

 

 

 

$

141,637

 

 

The Company invests in U.S. Treasuries, U.S. agency and high quality municipal bonds which mature at par value and are all paying their coupons on schedule. The Company has therefore concluded there is currently no other than temporary impairment of its investments and will continue to recognize unrealized gains and losses in other comprehensive income (loss). During the three months ended March 31, 2017, the Company had immaterial realized gains and losses. The Company uses the specific investment identification method to calculate realized gains and losses and amounts reclassified out of other comprehensive income to net income. As of March 31, 2017, the Company has 21 investments in an unrealized loss position in its portfolio. The Company earned interest income of $0.3 million during the three months ended March 31, 2017. The following table summarizes the Company’s portfolio of available-for-sale securities by contractual maturity as of March 31, 2017:

 

 

 

 

 

 

 

 

 

 

March 31, 2017

 

 

 

Amortized
Cost

 

Fair
Value

 

 

 

(in thousands)

 

Less than one year

 

$

39,169

 

$

39,100

 

Greater than one year but less than five years

 

 

68,048

 

 

67,592

 

Total

 

$

107,217

 

$

106,692